# CDW Corp: financial statements, quarterly

CDW · Nasdaq · CIK 1402057 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdw.md) · [Financials](/companies/cdw/financials.md) · [Filings](/companies/cdw/filings.md) · [Insiders](/companies/cdw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,628](/filings/0001402057-24-000182.md) | [5,019 d](/filings/0001402057-26-000011.md) | [4,873](/filings/0001402057-25-000096.md) | [5,423](/filings/0001402057-25-000145.md) | [5,517](/filings/0001402057-25-000193.md) | [5,186 d](/filings/0001402057-26-000011.md) | [5,199](/filings/0001402057-26-000025.md) | [5,977](/filings/0001402057-26-000065.md) | [5,737](/filings/0001402057-25-000193.md) | [5,511 d](/filings/0001402057-26-000011.md) | [5,680](/filings/0001402057-26-000025.md) | [6,572](/filings/0001402057-26-000065.md) |
| Cost of revenue | $m | [4,401](/filings/0001402057-24-000182.md) | [3,865 d](/filings/0001402057-26-000011.md) | [3,809](/filings/0001402057-25-000096.md) | [4,240](/filings/0001402057-25-000145.md) | [4,316](/filings/0001402057-25-000193.md) | [4,031 d](/filings/0001402057-26-000011.md) | [4,077](/filings/0001402057-26-000025.md) | [4,735](/filings/0001402057-26-000065.md) | [4,482](/filings/0001402057-25-000193.md) | [4,257 d](/filings/0001402057-26-000011.md) | [4,490](/filings/0001402057-26-000025.md) | [5,252](/filings/0001402057-26-000065.md) |
| Gross profit | $m | [1,228](/filings/0001402057-24-000182.md) | [1,154 d](/filings/0001402057-26-000011.md) | [1,063](/filings/0001402057-25-000096.md) | [1,183](/filings/0001402057-25-000145.md) | [1,201](/filings/0001402057-25-000193.md) | [1,155 d](/filings/0001402057-26-000011.md) | [1,122](/filings/0001402057-26-000025.md) | [1,241](/filings/0001402057-26-000065.md) | [1,256](/filings/0001402057-25-000193.md) | [1,254 d](/filings/0001402057-26-000011.md) | [1,190](/filings/0001402057-26-000025.md) | [1,320](/filings/0001402057-26-000065.md) |
| Selling, general and administrative | $m | [749](/filings/0001402057-24-000182.md) | [719 d](/filings/0001402057-26-000011.md) | [735](/filings/0001402057-25-000096.md) | [750](/filings/0001402057-25-000145.md) | [719](/filings/0001402057-25-000193.md) | [747 d](/filings/0001402057-26-000011.md) | [761](/filings/0001402057-26-000025.md) | [821](/filings/0001402057-26-000065.md) | [812](/filings/0001402057-25-000193.md) | [824 d](/filings/0001402057-26-000011.md) | [814](/filings/0001402057-26-000025.md) | [891](/filings/0001402057-26-000065.md) |
| Operating income | $m | [478](/filings/0001402057-24-000182.md) | [435 d](/filings/0001402057-26-000011.md) | [328](/filings/0001402057-25-000096.md) | [433](/filings/0001402057-25-000145.md) | [482](/filings/0001402057-25-000193.md) | [409 d](/filings/0001402057-26-000011.md) | [361](/filings/0001402057-26-000025.md) | [420](/filings/0001402057-26-000065.md) | [443](/filings/0001402057-25-000193.md) | [431 d](/filings/0001402057-26-000011.md) | [376](/filings/0001402057-26-000025.md) | [429](/filings/0001402057-26-000065.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [104](/filings/0001402057-24-000182.md) | [84.6 d](/filings/0001402057-26-000011.md) | [60.5](/filings/0001402057-25-000096.md) | [98.6](/filings/0001402057-25-000145.md) | [111](/filings/0001402057-25-000193.md) | [87.3 d](/filings/0001402057-26-000011.md) | [79.1](/filings/0001402057-26-000025.md) | [93.7](/filings/0001402057-26-000065.md) | [98.4](/filings/0001402057-25-000193.md) | [89.6 d](/filings/0001402057-26-000011.md) | [83.6](/filings/0001402057-26-000025.md) | [98.5](/filings/0001402057-26-000065.md) |
| Net income | $m | [316](/filings/0001402057-24-000182.md) | [296 d](/filings/0001402057-26-000011.md) | [216](/filings/0001402057-25-000096.md) | [281](/filings/0001402057-25-000145.md) | [316](/filings/0001402057-25-000193.md) | [264 d](/filings/0001402057-26-000011.md) | [225](/filings/0001402057-26-000025.md) | [271](/filings/0001402057-26-000065.md) | [291](/filings/0001402057-25-000193.md) | [280 d](/filings/0001402057-26-000011.md) | [235](/filings/0001402057-26-000025.md) | [274](/filings/0001402057-26-000065.md) |
| Diluted EPS | $ per share | [2.32](/filings/0001402057-24-000182.md) | not reported | [1.59](/filings/0001402057-25-000096.md) | [2.07](/filings/0001402057-25-000145.md) | [2.34](/filings/0001402057-25-000193.md) | not reported | [1.69](/filings/0001402057-26-000025.md) | [2.05](/filings/0001402057-26-000065.md) | [2.21](/filings/0001402057-25-000193.md) | not reported | [1.82](/filings/0001402057-26-000025.md) | [2.15](/filings/0001402057-26-000065.md) |
| Basic EPS | $ per share | [2.35](/filings/0001402057-24-000182.md) | not reported | [1.61](/filings/0001402057-25-000096.md) | [2.10](/filings/0001402057-25-000145.md) | [2.37](/filings/0001402057-25-000193.md) | not reported | [1.70](/filings/0001402057-26-000025.md) | [2.06](/filings/0001402057-26-000065.md) | [2.22](/filings/0001402057-25-000193.md) | not reported | [1.82](/filings/0001402057-26-000025.md) | [2.16](/filings/0001402057-26-000065.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001402057-23-000169.md) | [0.6](/filings/0001402057-25-000018.md) | [0.8](/filings/0001402057-24-000088.md) | [0.7](/filings/0001402057-24-000138.md) | [0.9](/filings/0001402057-24-000182.md) | [0.5](/filings/0001402057-26-000011.md) | [0.5](/filings/0001402057-25-000096.md) | [0.5](/filings/0001402057-25-000145.md) | [0.5](/filings/0001402057-25-000193.md) | [0.6](/filings/0001402057-26-000065.md) | [0.6](/filings/0001402057-26-000025.md) | [0.4](/filings/0001402057-26-000065.md) |
| Current assets | $bn | [6.5](/filings/0001402057-23-000169.md) | [6.7](/filings/0001402057-25-000018.md) | [6.6](/filings/0001402057-24-000088.md) | [7.0](/filings/0001402057-24-000138.md) | [7.7](/filings/0001402057-24-000182.md) | [7.4](/filings/0001402057-26-000011.md) | [7.7](/filings/0001402057-25-000096.md) | [7.8](/filings/0001402057-25-000145.md) | [7.8](/filings/0001402057-25-000193.md) | [8.5](/filings/0001402057-26-000065.md) | [9.0](/filings/0001402057-26-000025.md) | [9.7](/filings/0001402057-26-000065.md) |
| Total assets | $bn | [12.9](/filings/0001402057-23-000169.md) | [13.3](/filings/0001402057-25-000018.md) | [13.2](/filings/0001402057-24-000088.md) | [13.6](/filings/0001402057-24-000138.md) | [14.4](/filings/0001402057-24-000182.md) | [14.7](/filings/0001402057-26-000011.md) | [15.0](/filings/0001402057-25-000096.md) | [15.3](/filings/0001402057-25-000145.md) | [15.2](/filings/0001402057-25-000193.md) | [16.0](/filings/0001402057-26-000065.md) | [16.5](/filings/0001402057-26-000025.md) | [17.3](/filings/0001402057-26-000065.md) |
| Current liabilities | $bn | [4.8](/filings/0001402057-23-000169.md) | [5.4](/filings/0001402057-25-000018.md) | [5.3](/filings/0001402057-24-000088.md) | [6.2](/filings/0001402057-24-000138.md) | [5.5](/filings/0001402057-24-000182.md) | [5.5](/filings/0001402057-26-000011.md) | [5.8](/filings/0001402057-25-000096.md) | [5.8](/filings/0001402057-25-000145.md) | [5.6](/filings/0001402057-25-000193.md) | [7.2](/filings/0001402057-26-000065.md) | [7.7](/filings/0001402057-26-000025.md) | [8.3](/filings/0001402057-26-000065.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | [5.7](/filings/0001402057-23-000169.md) | [5.0](/filings/0001402057-25-000018.md) | [5.0](/filings/0001402057-24-000088.md) | [4.4](/filings/0001402057-24-000138.md) | [5.6](/filings/0001402057-24-000182.md) | [5.6](/filings/0001402057-26-000011.md) | [5.6](/filings/0001402057-25-000096.md) | [5.6](/filings/0001402057-25-000145.md) | [5.6](/filings/0001402057-25-000193.md) | [4.6](/filings/0001402057-26-000065.md) | [4.6](/filings/0001402057-26-000025.md) | [4.8](/filings/0001402057-26-000065.md) |
| Current portion of debt | $bn | [0.0](/filings/0001402057-23-000169.md) | [0.6](/filings/0001402057-25-000018.md) | [0.6](/filings/0001402057-24-000088.md) | [1.2](/filings/0001402057-24-000138.md) | [0.4](/filings/0001402057-24-000182.md) | [0.2](/filings/0001402057-26-000011.md) | [0.2](/filings/0001402057-25-000096.md) | [0.0](/filings/0001402057-25-000145.md) | [0.0](/filings/0001402057-25-000193.md) | [1.0](/filings/0001402057-26-000065.md) | [1.0](/filings/0001402057-26-000025.md) | [1.0](/filings/0001402057-26-000065.md) |
| Shareholders' equity | $bn | [1.8](/filings/0001402057-24-000182.md) | [2.0](/filings/0001402057-26-000011.md) | [2.1](/filings/0001402057-25-000145.md) | [2.2](/filings/0001402057-25-000193.md) | [2.3](/filings/0001402057-25-000193.md) | [2.4](/filings/0001402057-26-000065.md) | [2.3](/filings/0001402057-26-000065.md) | [2.5](/filings/0001402057-26-000065.md) | [2.5](/filings/0001402057-25-000193.md) | [2.6](/filings/0001402057-26-000065.md) | [2.6](/filings/0001402057-26-000065.md) | [2.4](/filings/0001402057-26-000065.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [469 d](/filings/0001402057-24-000182.md) | [537 d](/filings/0001402057-26-000011.md) | [440](/filings/0001402057-25-000096.md) | [150 d](/filings/0001402057-25-000145.md) | [342 d](/filings/0001402057-25-000193.md) | [345 d](/filings/0001402057-26-000011.md) | [287](/filings/0001402057-26-000025.md) | [156 d](/filings/0001402057-26-000065.md) | [328 d](/filings/0001402057-25-000193.md) | [434 d](/filings/0001402057-26-000011.md) | [275](/filings/0001402057-26-000025.md) | [(55.1) d](/filings/0001402057-26-000065.md) |
| Capital expenditure | $m | [43.4 d](/filings/0001402057-24-000182.md) | [33.5 d](/filings/0001402057-26-000011.md) | [29.5](/filings/0001402057-25-000096.md) | [30.9 d](/filings/0001402057-25-000145.md) | [33.6 d](/filings/0001402057-25-000193.md) | [28.6 d](/filings/0001402057-26-000011.md) | [26.9](/filings/0001402057-26-000025.md) | [22.5 d](/filings/0001402057-26-000065.md) | [29.8 d](/filings/0001402057-25-000193.md) | [37.9 d](/filings/0001402057-26-000011.md) | [26.4](/filings/0001402057-26-000025.md) | [27.5 d](/filings/0001402057-26-000065.md) |
| Dividends paid | $m | [79.1 d](/filings/0001402057-24-000182.md) | [83.1 d](/filings/0001402057-26-000011.md) | [83.3](/filings/0001402057-25-000096.md) | [83.0 d](/filings/0001402057-25-000145.md) | [82.7 d](/filings/0001402057-25-000193.md) | [83.1 d](/filings/0001402057-26-000011.md) | [82.8](/filings/0001402057-26-000025.md) | [82.3 d](/filings/0001402057-26-000065.md) | [81.8 d](/filings/0001402057-25-000193.md) | [81.7 d](/filings/0001402057-26-000011.md) | [81.1](/filings/0001402057-26-000025.md) | [79.8 d](/filings/0001402057-26-000065.md) |
| Share repurchases | $m | [53.9 d](/filings/0001402057-24-000182.md) | [50.0 d](/filings/0001402057-26-000011.md) | [52.1](/filings/0001402057-25-000096.md) | [202 d](/filings/0001402057-25-000145.md) | [100 d](/filings/0001402057-25-000193.md) | [146 d](/filings/0001402057-26-000011.md) | [200](/filings/0001402057-26-000025.md) | [150 d](/filings/0001402057-26-000065.md) | [150 d](/filings/0001402057-25-000193.md) | [153 d](/filings/0001402057-26-000011.md) | [201](/filings/0001402057-26-000025.md) | [344 d](/filings/0001402057-26-000065.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [137](/filings/0001402057-23-000169.md) | [137](/filings/0001402057-24-000088.md) | [136](/filings/0001402057-24-000138.md) | [136](/filings/0001402057-24-000182.md) | [136](/filings/0001402057-25-000096.md) | [136](/filings/0001402057-25-000145.md) | [135](/filings/0001402057-25-000193.md) | [134](/filings/0001402057-26-000025.md) | [132](/filings/0001402057-26-000065.md) | [132](/filings/0001402057-25-000193.md) | [130](/filings/0001402057-26-000025.md) | [127](/filings/0001402057-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,017,426 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001402057-26-000065.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.